The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
You need to invest in what you believe in. I am a paramedic so I see cath labs all the time in that I take pts to them. Catheter emplacements are a NEEDED operation, it saves your life. So this company's "moat" is both it's revolutionary tech and the necessity of its product. The HUGE push in emergency medicine these days is "door to balloon", this means hospitals are just now pushing for quicker cath times. The longer a pt has a blockage (heart attack) the worse that pt will be. "Balloon" stands for the catheter being blown up and thus remove the blockage in the pt's heart. if the Niobe system does it in half the time as a traditional cath operation (and HNSN), you can bet that hospitals and insurance companies will be pushing for this system. I am a bull for this company for these reasons.